Lactoferrin Alleviates Inflammation and Regulates Gut Microbiota Composition in H5N1-Infected Mice

• Published in: Nutrients 2023-07, Vol.15 (15), p.3362
• Main Authors: Huang, Yanyi, Zhang, Peiyang, Han, Shuyi, He, Hongxuan
• Format: Article
• Language: English
• Subjects: Animals; Avian flu; Avian influenza; Avian influenza viruses; Bacteria - genetics; Biotechnology; Colon; Diet; Feeds; Gastrointestinal Microbiome; Gene expression; gut microbiota; H5N1; Health aspects; Infection; Infections; Inflammation; Inflammation - drug therapy; Inflammation - pathology; Inflammatory bowel disease; influenza; Influenza A Virus, H5N1 Subtype - physiology; Intestinal Diseases - pathology; Intestines - microbiology; Laboratory animals; lactoferrin; Lactoferrin - pharmacology; Lactoferrins; Lungs; Mice; Microbiota; Microbiota (Symbiotic organisms); Microorganisms; Peptides; Software; Viruses
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu15153362

The impact of lactoferrin, an antimicrobial peptide (AMP) with iron-binding properties, on the intestinal barrier and microflora of mice infected with highly pathogenic avian influenza A (H5N1) virus remains unclear. To investigate the effects of lactoferrin on the histopathology and intestinal microecological environment, we conducted a study using H5N1-infected mice. H5N1 infection resulted in pulmonary and intestinal damage, as well as an imbalance in gut microbiota, significantly increasing the abundance of pathogenic bacteria such as and . The consumption of lactoferrin in the diet alleviated lung injury and restored the downregulation of the INAVA gene and intestinal dysfunction caused by H5N1 infection. Lactoferrin not only reduced lung and intestinal injury, but also alleviated inflammation and reversed the changes in intestinal microflora composition while increasing the abundance of beneficial bacteria. Moreover, lactoferrin rebalanced the gut microbiota and partially restored intestinal homeostasis. This study demonstrated that lactoferrin exerts its effects on the intestinal tract, leading to improvements in gut microbiota and restoration of the integrity of both the intestinal wall and lung tissue. These findings support the notion that lactoferrin may be a promising candidate for systemic treatment of influenza by locally acting on the intestine and microbiota.